Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 121407, 8 pages
http://dx.doi.org/10.1155/2013/121407
Research Article

Different Effects of Six Antibiotics and Ten Traditional Chinese Medicines on Shiga Toxin Expression by Escherichia coli O157:H7

State Key Laboratory of Microbial Technology, School of Life Sciences, Shandong University, 27 Shanda Nanlu, Jinan 250100, China

Received 7 April 2013; Revised 17 June 2013; Accepted 22 June 2013

Academic Editor: Jairo Kenupp Bastos

Copyright © 2013 Mei Ling Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Watanabe, A. Wada, Y. Inagaki, K.-I. Itoh, and K. Tamura, “Outbreaks of enterohaemorrhagic Escherichia coli O157:H7 infection by two different genotype strains in Japan, 1996,” The Lancet, vol. 348, no. 9030, pp. 831–832, 1996. View at Google Scholar · View at Scopus
  2. J. M. Rangel, P. H. Sparling, C. Crowe, P. M. Griffin, and D. L. Swerdlow, “Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982–2002,” Emerging Infectious Diseases, vol. 11, no. 4, pp. 603–609, 2005. View at Google Scholar · View at Scopus
  3. M. E. Doyle, J. Archer, C. W. Kaspar, and R. Weiss, “Human illness caused by E.coli O157:H7 from food and non-food sources,” FRI Briefings, pp. 1–37, 2006.
  4. C. Frank, D. Werber, J. P. Cramer et al., “Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany,” The New England Journal of Medicine, vol. 365, no. 19, pp. 1771–1780, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Tzschoppe, A. Martin, and L. Beutin, “A rapid procedure for the detection and isolation of enterohaemorrhagic Escherichia coli (EHEC) serogroup O26, O103, O111, O118, O121, O145 and O157 strains and the aggregative EHEC O104:H4 strain from ready-to-eat vegetables,” International Journal of Food Microbiology, vol. 152, no. 1-2, pp. 19–30, 2012. View at Google Scholar · View at Scopus
  6. S. A. Wani, F. Pandit, I. Samanta, M. A. Bhat, and A. S. Buchh, “Molecular epidemiology of Shiga toxin-producing Escherichia coli in India,” Current Science, vol. 87, no. 10, pp. 1345–1353, 2004. View at Google Scholar · View at Scopus
  7. M. Neupane, A. Mitra, D. W. Lacher, S. D. Manning, J. T. Riordan, and G. S. Abu-Ali, “Shiga toxin 2 overexpression in Escherichia coli O157:H7 strains associated with severe human disease,” Microbial Pathogenesis, vol. 51, no. 6, pp. 466–470, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. R. A. Safadi, S. AA. Galeb, R. E. Sloup et al., “Correlation between in vivo biofilm formation and virulence gene expression in Escherichia coli O104:H4,” Plos One, vol. 7, no. 7, Article ID e41628, 2012. View at Google Scholar
  9. R. L. Siegler, T. G. Obrig, T. J. Pysher, V. L. Tesh, N. D. Denkers, and F. B. Taylor, “Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome,” Pediatric Nephrology, vol. 18, no. 2, pp. 92–96, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. W. Xiong, P. Wang, R. T. Lan et al., “A novel Escherichia coli O157:H7 clone causing a major hemolytic uremic syndrome outbreak in China,” PLoS One, vol. 7, no. 4, Article ID e36144, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. C. S. Wong, S. Jelacic, R. L. Habeeb, S. L. Watkins, and P. I. Tarr, “The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections,” The New England Journal of Medicine, vol. 342, no. 26, pp. 1930–1936, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Köhler, H. Karch, and H. Schmidt, “Antibacterials that are used as growth promoters in animal husbandry can affect the release of Shiga-toxin-2-converting bacteriophages and Shiga toxin 2 from Escherichia coli strains,” Microbiology, vol. 146, no. 5, pp. 1085–1090, 2000. View at Google Scholar · View at Scopus
  13. K. P. Stefani, Factors Regulating the Production of STX2 in Escherichia Coli O157: H7, Proquest Uni Dissertation Publishing, 2011.
  14. T. de Sablet, Y. Bertin, M. Vareille et al., “Differential expression of stx2 variants in Shiga toxin-producing Escherichia coli belonging to seropathotypes A and C,” Microbiology, vol. 154, no. 1, pp. 176–186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Shaikh and P. I. Tarr, “Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications,” Journal of Bacteriology, vol. 185, no. 12, pp. 3596–3605, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. C. M. McGannon, C. A. Fuller, and A. A. Weiss, “Different classes of antibiotics differentially influence shiga toxin production,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 9, pp. 3790–3798, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Ohara, S. Kojio, I. Taneike et al., “Effects of azithromycin on Shiga toxin production by Escherichia coli and subsequent host inflammatory response,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 11, pp. 3478–3483, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Mohsin, A. Haque, A. Ali et al., “Effects of ampicillin, gentamicin, and cefotaxime on the release of shiga toxins from shiga toxin-producing Escherichia coli isolated during a diarrhea episode in Faisalabad, Pakistan,” Foodborne Pathogens and Disease, vol. 7, no. 1, pp. 85–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Uemura, M. Sueyoshi, Y. Taura, and H. Nagatomo, “Effect of antimicrobial agents on the production and release of shiga toxin by enterotoxaemic Escherichia coli isolates from pigs,” Journal of Veterinary Medical Science, vol. 66, no. 8, pp. 899–903, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Shiomi, M. Togawa, K. Fujita, and R. Murata, “Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7,” Pediatrics International, vol. 41, no. 2, pp. 228–232, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Ichinohe, Y. Ohara-Nemoto, T. K. Nemoto, S. Kimura, and S. Ichinohe, “Effects of fosfomycin on Shiga toxin-producing Escherichia coli: quantification of copy numbers of Shiga toxin-encoding genes and their expression levels using real-time PCR,” Journal of Medical Microbiology, vol. 58, no. 7, pp. 971–973, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. T. J. Ochoa, J. Chen, C. M. Walker, E. Gonzales, and T. G. Cleary, “Rifaximin does not induce toxin production or phage-mediated lysis of shiga toxin-producing Escherichia coli,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 8, pp. 2837–2841, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. J. G. Li and X. H. Yu, The Chinese Medicine in Infectious Diseases, Chinese Medicine Science and Technology Press, Beijing, China, 1997.
  24. National Pharmacopoeia Committee, Pharmacopoeia of the People's Republic of China ( 2010), National Pharmacopoeia Committee, 2010.
  25. J. L. Jin, G. Q. Hua, Z. Meng, and P. J. Gao, “Mechanisms of antibacterial activity of berberine and the reasons for bacteria not resist to it,” Chinese Herbal Medicines, vol. 3, no. 1, pp. 27–35, 2011. View at Google Scholar
  26. C.-S. Liu, T. M. Cham, C. H. Yang, H.-W. Chang, C. H. Chen, and L. Y. Chuang, “Antibacterial properties of Chinese herbal medicines against nosocomial antibiotic resistant strains of Pseudomonas aeruginosa in Taiwan,” American Journal of Chinese Medicine, vol. 35, no. 6, pp. 1047–1060, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Meng, J. L. Jin, Y. Q. Liu, and P. J. Gao, “The induction and elimination of bacteria's resistance,” Chinese Pharmacological Bulletin, vol. 19, no. 9, pp. 1047–1051, 2003. View at Google Scholar · View at Scopus
  28. Y. Lee, H. Yeo, S. H. Liu et al., “Increased anti-P-glycoprotein activity of baicalein by alkylation on the A ring,” Journal of Medicinal Chemistry, vol. 47, no. 22, pp. 5555–5566, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Huerta, K. Mihalik, S. H. Crixell, and D. A. Vattem, “Herbs, spices and medicinal plants used in hispanic traditional medicine can decrease quorum sensing dependent virulence in Pseudomonas aeruginosa,” International Journal of Applied Research in Natral Products, vol. 1, no. 2, pp. 9–15, 2008. View at Google Scholar
  30. C. J. Chang, T. F. Tzeng, S. S. Liou, Y. S. Chang, and I. M. Liu, “Acute and 28-day subchronic oral toxicity of an ethanol extract of Zingiber zerumbet (L.) Smith in rodents,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 608284, 11 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. J. L. Jin, H. Zhang, B. Liu, Y. P. Cai, and P. J. Gao, “Study on mutagenicity of Enphorbia lunulata Bge. decoction in vitro,” Medicineal Plant, vol. 5, no. 1, pp. 28–31, 2013. View at Google Scholar
  32. B. Liu, J. L. Jin, Y. F. Cheng, H. Q. Zhang, and P. J. Gao, “A modified suspension test for estimating the mutagenicity of samples containing free and (or) protein-bound histidine,” Canadian Journal of Microbiology, vol. 55, no. 2, pp. 146–153, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Yamasaki, M. Asakura, S. B. Neogi, A. Hinenoya, E. Iwaoka, and S. Aoki, “Inhibition of virulence potential of Vibrio cholerae by natural compounds,” Indian Journal of Medical Research, vol. 133, no. 2, pp. 232–239, 2011. View at Google Scholar · View at Scopus
  34. H. T. Li, H. M. Qin, W. H. Wang, G. J. Li, C. M. Wu, and J. X. Song, “Effect of andrographolide on QS regulating virulence factors production in Pseudomonas aeruginosa,” Zhongguo Zhongyao Zazhi, vol. 31, no. 12, pp. 1015–1017, 2006. View at Google Scholar · View at Scopus
  35. X. Jiang, P. Yu, J. Jiang et al., “Synthesis and evaluation of antibacterial activities of andrographolide analogues,” European Journal of Medicinal Chemistry, vol. 44, no. 7, pp. 2936–2943, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. J. L. Jin, B. Liu, H. Zhang, X. Tian, Y. P. Cai, and P. J. Gao, “Mutagenicity of Chinese traditional medicine Semen Armeniacae amarum by two modified Ames tests,” BMC Complementary and Alternative Medicine, vol. 9, pp. 43–50, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Andrews, “Determination of minimum inhibitory concentrations,” Journal of Antimicrobial Chemotherapy, vol. 48, no. 1, pp. 5–16, 2002. View at Google Scholar
  38. National Committee for Clinical Laboratory Standards (NCCLS), Methods For Dilution Antimicrobial Susceptibility Test For Bacteria That Grow Aerobically, 5th edition, Approved standard M7-A5.
  39. N. T. Perna, G. F. Mayhew, G. Pósfai et al., “Molecular evolution of a pathogenicity island from enterohemorrhagic Escherichia coli O157:H7,” Infection and Immunity, vol. 66, no. 8, pp. 3810–3817, 1998. View at Google Scholar · View at Scopus
  40. ISO 13829, “Water quality-determination of genototoxicty of water and waste water using the umu-test,” 2000.
  41. P. Quillardet and M. Hofnung, “The SOS chromotest: a review,” Mutation Research, vol. 297, no. 3, pp. 235–279, 1993. View at Publisher · View at Google Scholar · View at Scopus
  42. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-CT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. P. T. Kimmitt, C. R. Harwood, and M. R. Barer, “Toxin gene expression by Shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response,” Emerging Infectious Diseases, vol. 6, no. 5, pp. 458–465, 2000. View at Google Scholar · View at Scopus
  44. B. Martina, E. A. Idelevich, W. Zhang et al., “Effects of antibiotics on shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 6, pp. 3277–3282, 2012. View at Google Scholar
  45. J. J. Yao, Q. Y. Zhang, J. Min, J. He, and Z. N. Yu, “Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 1, pp. 56–59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Yu, X. Li, W. Deng et al., “Influence of traditional Chinese medicine on spermatozoa infected in vitro with Escherichia coli,” Andrologia, vol. 43, no. 5, pp. 321–326, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Oda, S. I. Nakamura, I. Oki, T. Kato, and H. Shinagawa, “Evaluation of the new sytem (umu-test) for the detection of environmental mutagens and carcinogens,” Mutation Research, vol. 147, no. 5, pp. 219–229, 1985. View at Google Scholar · View at Scopus
  48. Z. Y. Dai, Y. K. Liu, and F. Wang, Practical Antibacterial Material Medica, Shanghai Science and Technology Press, 2nd edition, 1998.
  49. B. Michel, “After 30 years of study, the bacterial SOS response still surprises us,” PLoS Biology, vol. 3, no. 7, p. e255, 2005. View at Google Scholar · View at Scopus
  50. S. E. Burckhardt, R. Woodgate, R. H. Scheuermann, and H. Echols, “UmuD mutagenesis protein of Escherichia coli: overproduction, purification, and cleavage by RecA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 6, pp. 1811–1815, 1988. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Snyder and W. Champness, Molecular Genetics of Bacteria, ASM Press, Washington, DC, USA, 1997.
  52. C. Janion, “Inducible SOS response system of DNA repair and mutagenesis in Escherichia coli,” International Journal of Biological Sciences, vol. 4, no. 6, pp. 338–344, 2008. View at Google Scholar · View at Scopus
  53. J. L. Jin, W. C. Zhang, Y. Li, Y. Zhao, F. Wang, and P. J. Gao, “Bactericidal effect of soybean peroxidase-hydrogen peroxide-potassium iodide system,” Acta Microbiologica Sinica, vol. 51, no. 3, pp. 393–401, 2011. View at Google Scholar · View at Scopus
  54. W. X. Jia, Medical Microbiology, People's Medical Press, Beijing, China, 2001.
  55. H. Odeberg and I. Olsson, “Microbicidal mechanisms of human granulocytes: synergistic effects of granulocyte elastase and myeloperoxidase or chymotrypsin like cationic protein,” Infection and Immunity, vol. 14, no. 6, pp. 1276–1283, 1976. View at Google Scholar · View at Scopus
  56. M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, “Free radicals, metals and antioxidants in oxidative stress-induced cancer,” Chemico-Biological Interactions, vol. 160, no. 1, pp. 1–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. P. J. O'Brien, “Peroxidases,” Chemico-Biological Interactions, vol. 129, no. 1-2, pp. 113–139, 2000. View at Publisher · View at Google Scholar · View at Scopus